tiprankstipranks
Advertisement
Advertisement
Amphastar Balances Margin Pain With Pipeline Gains
PremiumCompany AnnouncementsAmphastar Balances Margin Pain With Pipeline Gains
27d ago
Amphastar downgraded to Hold from Buy at Needham
Premium
The Fly
Amphastar downgraded to Hold from Buy at Needham
27d ago
Amphastar cut to Hold at Needham after ‘disappointing’ results
Premium
The Fly
Amphastar cut to Hold at Needham after ‘disappointing’ results
27d ago
Amphastar Expands Share Repurchase Authorization to Manage Equity
PremiumCompany AnnouncementsAmphastar Expands Share Repurchase Authorization to Manage Equity
3M ago
Amphastar Updates Executive Employment Agreements to Strengthen Leadership
Premium
Company Announcements
Amphastar Updates Executive Employment Agreements to Strengthen Leadership
3M ago
Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks
Premium
Company Announcements
Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks
3M ago
Amphastar Licenses ACTH Analog AMP-110 for North America
PremiumCompany AnnouncementsAmphastar Licenses ACTH Analog AMP-110 for North America
5M ago
Amphastar price target lowered to $30 from $31 at BofA
Premium
The Fly
Amphastar price target lowered to $30 from $31 at BofA
5M ago
Amphastar Pharmaceuticals Receives Buy Rating Following FDA Approval of AMP-015
Premium
Ratings
Amphastar Pharmaceuticals Receives Buy Rating Following FDA Approval of AMP-015
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100